Digital polymerase chain reaction (dPCR) technology is an advanced version of the polymerase chain reaction (PCR) technology that enables users to amplify and directly quantify nucleic acids, such as DNA, RNA, cDNA, and methylated DNA with a high level of precision. The technique allows users to statistically analyze PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear and digital signals.
One of the primary drivers for this market is the rise in the focus on disease diagnosis and drug discovery and development. This increase in focus on medical research and drug discovery and development of several diseases is mainly driven by pharmaceutical and biotechnology companies as well as by research institutes. Also, it has been observed that governments of many developed and developing countries have been supporting research for new drug discovery and development. dPCR technology plays a vital role in drug discovery and development and for gene expression profiling, nucleic acid sequencing, and pharmacogenomics. Consequently, the major pharmaceutical and biotechnology companies will increase their adoption of dPCR technology due to high specificity, high accuracy, and productive results in developing new drug candidates. Such factors are expected to propel growth in the global dPCR market during the forecast period.
The global dPCR market is largely fragmented with the presence of many international and regional players present across the globe. The demand for dPCR solutions will be high in emerging countries, especially the BRIC countries (Brazil, Russia, India, China, and South Africa), due to an increase in their investments in drug research activities in various fields, including diagnosis of cancer. This rise is expected to intensify the competition among vendors in the next few years.
The global dPCR market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on dPCR volume and value at global level, regional level and company level. From a global perspective, this report represents overall dPCR market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of dPCR in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their dPCR manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bio-Rad Laboratories
Fluidigm
RainDance Technologies
Thermo Fisher Scientific
Becton
Dickinson and Company
Exiqon
Formulatrix
Promega Corporation
Sigma-Aldrich
Stilla Technologies
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Consumables
Instruments
Segment by Application
Research Laboratories and Academic Institutes
Pharma and Biotech Companies
Hospitals and Diagnostic Centers
Clinical Research Organizations
Forensic Laboratories
Summary:
Get latest Market Research Reports on dPCR. Industry analysis & Market Report on dPCR is a syndicated market report, published as Global dPCR Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of dPCR market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.